Table 1.
Baseline characteristics of 1,390 men and 288 women admitted to a methadone treatment program in metropolitan Barcelona, Spain, between 1992 and 2010
| Men | Women | pvalue | |
|---|---|---|---|
| n = 1,390 | n = 288 | ||
| n (%) | n (%) | ||
| Age at admission (median, IQR) | 31 (26–36) | 30 (24–35) | 0.000 |
| Period of admission: | 0.972 | ||
| 1992-1996 | 505 (36.3) | 103 (35.8) | |
| 1997-2001 | 469 (33.7) | 97 (33.7) | |
| 2002-2006 | 250 (18.0) | 55 (19.1) | |
| 2007-2010 | 166 (11.9) | 33 (11.5) | |
| Social and drug use characteristics | |||
| Age at first heroin use (median, IQR) | 19 (17–22) | 19 (16–24) | 0.940 |
| Injection drug use (n = 1,562) | 992 (76.8) | 198 (73.1) | 0.184 |
| Unemployed (n = 1,560) | 703 (54.5) | 164 (60.5) | 0.072 |
| Primary school attainment (n = 1,552) | 1,065 (83.1) | 223 (82.3) | 0.735 |
| Prior incarceration (n = 1,480) | 610 (49.8) | 100 (39.4) | 0.003 |
| Co-morbidity | |||
| HIV infection (n = 1,343) | 582 (52.5) | 140 (59.8) | 0.040 |
| HCV infection (n = 727) | 443 (73.2) | 92 (75.4) | 0.617 |
| HBV infection (HBcAb+) (n = 708) | 369 (62.2) | 65 (56.5) | 0.250 |
| Psychiatric disorder (n = 1,567) | 311 (24.1) | 83 (30.3) | 0.031 |